page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Cocaine hydrochloride U.S.P

Category:

  • Local anesthetic

Description:

  • Ester local anesthetic

Indications:

  • Local anesthesia

  • Mucosal anesthesia

Contraindications:

  • Cardiac arrhythmias, coronary artery disease, hypertension, Tourette’s syndrome

  • Cerebrovascular disease, sensitivity to cocaine

Precautions:

  • Pregnancy category C; avoid breast feeding

  • Acutely ill, elderly, or debilitated patients

  • Inflammation or infection at site of application

Adverse Reactions (Side Effects):

  • CNS: agitation, excitement, anxiety, restlessness, apprehension, irritability, hallucinations, psychosis, seizures hyperreflexia, pressured speech, headache, CNS hemorrhage

  • CV: cardiac arrest, MI, PVC’s, heart failure, ventricular fibrillation/tachycardia

  • GI: abdominal pain, bowel ischemia, nausea, vomiting

  • GU: incontinence, renal tubular obstruction

  • MISC: muscle paralysis, nasal congestion, rhinitis, tremor, exophthalmos, fecal incontinence, rhabdomyolysis

Dosage:

Administered topically

  • Adult: 

    • Local or mucosal anesthesia: 

      • Apply 1%-4% solution by means of cotton applicators, packs, sprays, or by instillation. 

  • Child > 6 years: 

    • Local or mucosal anesthesia: 

      • Apply lowest effective dose

      • Do not use solutions greater than 4% due to risk of systemic toxicity; 

      • Do not exceed 1 mg/kg

Special Considerations:

  • Do not apply to eye or administer parenterally

  • Concomitant use of postganglionic blocking agents to control hypertension (guanadrel, guanethidine), sympathomimetics (dobutamine, dopamine, epinephrine), increase risk of cardiac arrhythmias or hypertension.

  • Labetalol (beta-blocker with alpha activity) has been successfully used to treat cocaine-induced hypertension.

Interactions:

  • MAOI’s

  • Cardiac glycosides

  • Cholinesterase inhibitors

  • Halogenated anesthetics

  • Nitrates

  • Sulfonamides

  • Sympathomimetics

  • Thyroid hormones

  • Tricyclic antidepressants

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site